Document Detail

Post-operative Treatment with Cisplatin and Vinorelbine in Chinese Patients with Non-small Cell Lung Cancer: A Clinical Prospective Analysis of 451 Patients.
MedLine Citation:
PMID:  23167369     Owner:  NLM     Status:  In-Data-Review    
Purpose: To determine the efficacy of post-operative chemotherapy with cisplatin plus vinorelbine (NP) in Chinese patients with non-small cell lung cancer (NSCLC). Methods: A total of 451 patients with NSCLCs at stages I, II, and IIIA after surgical resection were treated with cisplatin plus vinorelbine for 4 cycles or volunteers observed between January 2002 and November 2004 and were followed for five years. The therapeutic efficacy was evaluated with reference to overall survival (OS) and disease-free survival (DFS), and adverse effects were also recorded. Potential factors affecting the lengths of OS and DFS were analyzed by multivariate analysis. Results: Most patients (86.7%) completed at least 4 cycles of treatment. Patients with chemotherapy survived significantly longer than those in the observation group (p<0.001). The absolute improvements in the 2 and 5-year OS were 3.8% [hazard ratio (HR) =0.674, 95% confidence interval (CI): 0.554-0.820, P<0.0001] and 13.0% (HR=0.732, 95% CI: 0.579-0.926, P=0.009), respectively. The improvement at 4-year DFS was 2.1% (HR=0.327, 95% CI: 0.214-0.500, P<0.0001). Stratification analysis revealed that older age, histological type, pathological degree, but not the gender and smoking status, are independent factors affecting the length of survival in this population. Many patients (63.3%) had grade 1-III tolerable adverse effects, and there was no treatment-related death. Conclusions: Post-operative chemotherapy with NP regimen is effective and tolerable in Chinese patients with NSCLC.
Jing Wang; Feng Liu; Deng-Xiao Huang; Bin Jiang
Related Documents :
24484269 - Ebus-tbna for non-small cell lung cancer staging.
15999669 - Factors influencing tumour relapse after total laryngectomy.
23807749 - Visceral pleural invasion does not affect recurrence or overall survival among patients...
22994149 - Egfr overexpression in canine primary lung cancer: pathogenetic implications and impact...
23548249 - C-x-c motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as...
2324619 - Radiation induced tumours of the pharynx--can they be avoided?
22217739 - Melanoma: new insights and new therapies.
11068949 - Tumor hypoxia and anemia: impact on the efficacy of radiation therapy.
9247099 - Local control of piriform sinus cancer treated by radiation therapy alone.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Asian Pacific journal of cancer prevention : APJCP     Volume:  13     ISSN:  1513-7368     ISO Abbreviation:  Asian Pac. J. Cancer Prev.     Publication Date:  2012  
Date Detail:
Created Date:  2012-11-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130625     Medline TA:  Asian Pac J Cancer Prev     Country:  Thailand    
Other Details:
Languages:  eng     Pagination:  4505-10     Citation Subset:  IM    
Department of Oncology, No.3 People's Hospital Affiliated to Shanghai Jiao-Tong University School of Medicine (SJTU-SM), Shanghai, China E-mail :
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Time trends of esophageal cancer mortality in linzhou city during the period 1988-2010 and a bayesia...
Next Document:  Causes of delay in seeking treatment in patients with breast cancer in iran: a qualitative content a...